Novo Nordisk's deal with Korro is worth a total of $530 million in research and development (R&D) funding, milestone payments ...

Novo Nordisk on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar. The maker of weight loss drug Wegovy and ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with ...

Avicenna.ai SAS received U.S. FDA clearance for its Cina-Cspine algorithm, which uses machine learning technology to detect ...

The growth of highly sought-after weight-loss drugs like Wegovy and Ozempic, otherwise known as GLP-1 medications, represents ...

New data from Novo Nordisk’s phase 3 trial of an oral ... survodutide 4.8 mg versus 4.3% of controls. There was one red flag in the data, however; namely, that around a quarter (24.6%) of ...

FIRST IN PLAYBOOK — Senate Majority Leader CHUCK SCHUMER and House Minority Leader HAKEEM JEFFRIES are scheduled to attend a Congressional Gold Medal ceremony tomorrow honoring the 13 servicemembers ...

Terns Pharmaceuticals said its oral obesity drug reduced weight by an average of 4.9% in an early-stage study, joining ...

On Monday, former President Donald Trump rolled out World Liberty Financial, a crypto venture “led” by his sons, Donald Jr.

This undated photo provided by Novo Nordisk shows flags bearing the company's logo. (Novo Nordisk via AP) (Uncredited, © Martin Nordmark) A drug approved to treat ...